Inhibidores contra los factores de la coagulación adquiridos espontáneamente: Hemofilia B adquirida

Vista sencilla de ítem
dc.contributor.authorSossa Melo, Claudia Lucíaspa
dc.contributor.authorJiménez Sanguino, Sara Inésspa
dc.contributor.authorRodríguez, Pilarspa
dc.contributor.cvlacSossa Melo, Claudia Lucía [0001425704]spa
dc.contributor.googlescholarSossa Melo, Claudia Lucía [n1PL8iUAAAAJ&hl=es&oi=ao]spa
dc.contributor.orcidSossa Melo, Claudia Lucía [0000-0001-9876-222X]spa
dc.date.accessioned2020-10-27T14:22:19Z
dc.date.available2020-10-27T14:22:19Z
dc.date.issued2003-05-09
dc.description.abstractLos inhibidores adquiridos del factor IX son extremadamente raros. Un hombre de 70 años presentó sangrado profuso continuo luego de una cirugía ortopédica. Su PTT activado inicial fue 77.4 segundos (intervalo normal, 25-36) y su PT fue normal. La corrección del PTT activado expandido, resulta a favor del déficit del factor IX, confirmando el nivel de dicho factor 52%, con niveles normales de factor VIII. Esto fue realizado con plasma fresco congelado. Se presenta una revisión exhaustiva del tema. [Sossa Cl, Jiménez SI, Rodríguez P. Inhibidores contra los factores de la coagulación adquiridos espontáneamente: Hemofilia B adquirida.spa
dc.description.abstractenglishAcquired factor IX inhibitors are extremely rare. A 70-year-old man presented with continuous profuse bleeding after orthopedic surgery. His initial activated PTT was 77.4 seconds (normal range, 25-36) and his PT was normal. The correction of the expanded activated PTT results in favor of the factor IX deficiency, confirming the level of said factor 52%, with normal levels of factor VIII. This was performed with fresh frozen plasma. An exhaustive review of the topic is presented. [Sossa Cl, Jiménez SI, Rodríguez P. Inhibitors against spontaneously acquired coagulation factors: Acquired hemophilia B.eng
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga UNABspa
dc.identifier.issn2382-4603
dc.identifier.issn0123-7047
dc.identifier.repourlrepourl:https://repository.unab.edu.co
dc.identifier.urihttp://hdl.handle.net/20.500.12749/10524
dc.language.isospaspa
dc.publisherUniversidad Autónoma de Bucaramanga UNAB
dc.publisher.facultyFacultad Ciencias de la Saludspa
dc.publisher.programPregrado Medicinaspa
dc.relationhttps://revistas.unab.edu.co/index.php/medunab/article/view/268/251
dc.relation.referencesAledort L, Green D, Teitel J. Unexpected bleeding disorders. Hematology 2001; 111: 306-21spa
dc.relation.referencesFeinstein D, Green D, Teitel J, Federici A, Goodnight S. Diagnosis and management of patients with spontaneously acquired inhibitors of coagulation. Hematology 1999; 107: 192-208spa
dc.relation.referencesFeinstein D. Inhibitors of blood Coagulation. In: Hoffman R, Benz E, Shattil S, Furie B, Cohen H, Silberstein L, McGlave P (eds). Hematology. Basic principles and practice. Philadelphia: Churchill Livingstone, 2000: 1968spa
dc.relation.referencesStein D, Farley D, Ohler P, Costello P, Greenwood S, Vega R. Acquired factor IX in a patient without haemophilia. Haemophilia 2000; 6: 284spa
dc.relation.referencesKitchen ST, McCraw AN. Diagnosis of haemophilia and other bleeding disorders. A laboratory manual. World Federation of Hemophilia, 1992: 40-4spa
dc.relation.referencesJansen M, Schmaldienst S, Banyai S, et al. Treatment of coagulation inhibitors with extracorporeal inmmunoadsorption (Ig-Therasorb). Br J Haematol 2001; 112: 91-7spa
dc.relation.referencesLusher JM Inhibitor antibodies to factor VIII and factor IX: management. Semin Thromb Hemost 2000; 26:179-88spa
dc.relation.referencesArai M. Immune coagulation disorders (excluding antiphospholipid syndrome) Rinsho Byori 2001; 49:1000-4spa
dc.relation.referencesBoggio LN. Acquired hemophilia. Rev Clin Exp Hematol 2001; 5:389-404spa
dc.relation.referencesInhibitor Subcommittee of the Association of Hemophilia Clinic Directors of Canada. Suggestion for the management of factor VIII inhibitors. Haemophilia 2000 ; 6:52-9spa
dc.relation.urihttps://revistas.unab.edu.co/index.php/medunab/article/view/268
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.sourceMedUNAB; Vol. 6 Núm. 16 (2003): Efectos del vino tinto, Ciclo celular, Hemofilia B, Endometriosis y dolor, Diagnóstico de tuberculosis; 36-38
dc.subjectCiencias biomédicas
dc.subjectCiencias de la vida
dc.subjectInnovaciones en salud
dc.subjectInvestigaciones
dc.subject.keywordsHealth Scienceseng
dc.subject.keywordsMedicineeng
dc.subject.keywordsMedical Scienceseng
dc.subject.keywordsBiomedical Scienceseng
dc.subject.keywordsLife Scienceseng
dc.subject.keywordsInnovations in healtheng
dc.subject.keywordsResearcheng
dc.subject.keywordsAcquired hemophilia bspa
dc.subject.keywordsFactor IXeng
dc.subject.keywordsProlonged activated partial thromboplastin timeeng
dc.subject.keywordsCross-linked partial thromboplastin timeeng
dc.subject.lembCiencias médicasspa
dc.subject.lembCiencias de la saludspa
dc.subject.lembMedicinaspa
dc.subject.proposalHemofilia b adquiridaspa
dc.subject.proposalFactor IXspa
dc.subject.proposalTiempo de tromboplastina parcial activado prolongadospa
dc.subject.proposalTiempo de tromboplastina parcial cruzadospa
dc.titleInhibidores contra los factores de la coagulación adquiridos espontáneamente: Hemofilia B adquiridaspa
dc.title.translatedInhibitors against spontaneously acquired coagulation factors: Acquired hemophilia Beng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversionInfo:eu-repo/semantics/publishedVersion
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.type.localArtículospa
dc.type.redcolhttp://purl.org/redcol/resource_type/ART

Archivos

Bloque original

Mostrando 1 - 1 de 1
Miniatura
Nombre:
2003_Inhibidores_contra_los_factores.pdf
Tamaño:
571.54 KB
Formato:
Adobe Portable Document Format
Descripción:
Articulo
Descargar

Colecciones

Revista MedUNAB